Back to News
Market Impact: 0.2
Bavarian Nordic Appoints Stenvall As President & CEO
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Bavarian Nordic appointed Tarja Stenvall as President and CEO, effective October 15, 2026. The announcement is a notable executive leadership transition for the Danish biopharmaceutical company, with no financial, strategic, or guidance details disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
BAVA0.15
More News
- Bavarian Nordic wins UK contract for mpox and smallpox vaccine
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- NUBURU Completes Tekne Acquisition, Adding a $93 Million Defense & Dual-Use Program Portfolio and Advancing Expansion Across NATO and Allied Markets
- BTIG cuts Acumen Pharmaceuticals stock price target to $1 on trial results
- Jefferies raises West Pharmaceutical stock price target on HVP growth
- Microsoft's moolah mountain is more massive than ever. It just doesn't want the people who built it